4D Molecular Therapeutics, Inc. (FDMT) at a glance

4D Molecular Therapeutics, Inc. (FDMT) is a small-cap Healthcare company. It trades at $14.65, with a -182.3% profit margin and revenue growth of 21664.3%. It does not pay a dividend. Vestovix scores it 51/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Safety (1/100). It carries above-market volatility, so expect larger swings.

Price

$14.65

Market cap

$461.6M

P/E ratio

n/a

Dividend yield

None

Beta

2.76

52-week range

$5.97 to $16.93